Caredx to report first quarter 2024 financial results

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2024 after market close on thursday, may 9, 2024. company management will host a corresponding conference call beginning at 1:30 p.m. pacific time / 4:30 p.m. eastern time. in.
CDNA Ratings Summary
CDNA Quant Ranking